Pharmacology of bisphosphonates in pain
Autor: | Thomas M. Tzschentke |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Pharmacology medicine.medical_specialty Diphosphonates Bone cancer business.industry Analgesic Chronic pain Molecular Pharmacology medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Complex regional pain syndrome medicine Animals Vulvodynia Clinical efficacy Chronic Pain Intensive care medicine business 030217 neurology & neurosurgery |
Zdroj: | British Journal of Pharmacology. 178:1973-1994 |
ISSN: | 1476-5381 0007-1188 |
Popis: | The treatment of pain, in particular, chronic pain, remains a clinical challenge. This is particularly true for pain associated with severe or rare conditions, such as bone cancer pain, vulvodynia, or complex regional pain syndrome. Over the recent years, there is an increasing interest in the potential of bisphosphonates in the treatment of pain, although there are few papers describing antinociceptive and anti-hypersensitizing effects of bisphosphonates in various animal models of pain. There is also increasing evidence for clinical efficacy of bisphosphonates in chronic pain states, although the number of well-controlled studies is still limited. However, the mechanisms underlying the analgesic effects of bisphosphonates are still largely elusive. This review provides an overview of preclinical and clinical studies of bisphosphonates in pain and discusses various pharmacological mechanisms that have been postulated to explain their analgesic effects. LINKED ARTICLES: This article is part of a themed issue on The molecular pharmacology of bone and cancer-related bone diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.9/issuetoc. |
Databáze: | OpenAIRE |
Externí odkaz: |